Why Is ClinicalTrials.gov Still Struggling?

With no clear benefits to researchers, a frustrating user experience, and no penalties for non-compliance, ClinicalTrials.gov is becoming increasingly irrelevant to clinical researchers and the world at large with each passing day. What does this mean for public access to research results? Is an obligation to patients putting themselves at risk in trials being breached? Why has it failed to live up to its potential?

Sci-Hub and the Four Horsemen of the Internet

Sci-Hub sets a reprehensible example, but publishers cannot be content simply to stamp out such services. In order to evolve the industry into the future, publishers have to provide services that make Sci-Hub and its ilk seem old-fashioned and inconvenient to use.

An Interview with Jeffrey Beall

An interview with librarian and open access skeptic Jeffrey Beall. He discusses his work, the criteria for declaring an organization a “predatory publisher,” and how he would fix the scholarly communications system.

NYPL Shows Academic Libraries What "Public Domain" Means

The New York Public Library has now opened up hundreds of thousands of their digitized public-domain documents to unrestricted access and reuse, encouraging members the general public to exercise all the rights in those documents that the law gives them. Why aren’t more academic libraries doing the same thing?